Literature DB >> 22864779

Sporadic mutations and expression analysis of spleen tyrosine kinase gene in breast cancer: a preliminary report.

Uzma Inayat1, Mahmood A Kayani, Rani Faryal.   

Abstract

Spleen tyrosine kinase (Syk) is an intracellular receptor protein kinase involved in cell proliferation, differentiation and phagocytosis. Syk expression has been reported in cell lines of epithelial origin. The strong expression of Syk in mammary gland prompted research into its potential role in mammary carcinogenesis. Fresh Biopsy samples were collected from different hospitals of Pakistan. Single stranded conformational polymorphism and Semi quantitative reverse transcriptase polymerase chain reaction was used to investigate somatic mutations and expression alterations in twenty five breast cancer tumor tissues along with their adjacent normal control tissue. Statistical analysis was performed to explore Syk association with breast cancer risk. In the present study, DNA from tumor tissue was analyzed and mutations in the coding sequence and intronic sequence spanning the exonic region of the Syk gene were identified. Sequence analysis revealed two missense: g61096G>A, g65967G>A, one frame shift: g87413insA and one silent mutation g42841G>A in exonic region while nucleotide variations were also observed in intronic region including one splice site mutation. These mutations in Syk are first time being reported in breast cancer. In addition, this study also revealed that Syk mRNA expression was markedly reduced in tissues of breast cancer compared to their adjacent normal control tissue.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22864779

Source DB:  PubMed          Journal:  Pol J Pathol        ISSN: 1233-9687            Impact factor:   1.072


  4 in total

1.  Associations between polymorphisms in the SYK promoter and susceptibility to sporadic colorectal cancer in a Southern Han Chinese population - a short report.

Authors:  Hui Peng; Jun Huang; Ying Hu; Yisheng Wei; Huanliang Liu; Meijin Huang; Lei Wang; Jianping Wang
Journal:  Cell Oncol (Dordr)       Date:  2015-04-29       Impact factor: 6.730

2.  Retinoblastoma (RB1) pocket domain mutations and promoter hyper-methylation in head and neck cancer.

Authors:  Maimoona Sabir; Ruqia Mehmood Baig; Kashif Ali; Ishrat Mahjabeen; Muhammad Saeed; Mahmood Akhtar Kayani
Journal:  Cell Oncol (Dordr)       Date:  2014-06-03       Impact factor: 6.730

3.  SYK allelic loss and the role of Syk-regulated genes in breast cancer survival.

Authors:  Jan Blancato; Ashley Graves; Banafsheh Rashidi; Maria Moroni; Leopold Tchobe; Metin Ozdemirli; Bhaskar Kallakury; Kepher H Makambi; Catalin Marian; Susette C Mueller
Journal:  PLoS One       Date:  2014-02-11       Impact factor: 3.240

4.  Inhibition of SYK kinase does not confer a pro-proliferative or pro-invasive phenotype in breast epithelium or breast cancer cells.

Authors:  David J Lamb; Aleksander Rust; Albin Rudisch; Tobias Glüxam; Nathalie Harrer; Herwig Machat; Ingrid Christ; Florian Colbatzky; Andreas Wernitznig; Annika Osswald; Wolfgang Sommergruber
Journal:  Oncotarget       Date:  2020-04-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.